drugset / Trial / NCT01521117

The Effect of Donepezil on Gait and Balance in Parkinson's Disease

NCT01521117

Phase 4 Completed 21 enrolled Oregon Health and Science University
RandomizedCrossoverTriple-blindTreatment

Summary

This study involves Parkinson's disease (PD). Symptoms include slow movement, tremor, and muscle rigidity. Current medications for the treatment of PD do not improve gait and balance difficulties in individuals with PD. Donepezil (study drug) has been found to reduce falls in individuals with PD. The mechanism in which this reduction of falls occurs is unclear. The investigators study will look at what aspects of gait and balance are improved by the study drug. The study drug is not approved to treat PD in the United States or other countries because we do not know enough about it.

Timeline

Start
2011-12
Primary completion
2012-04
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg

Indications